These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1479558)

  • 1. Pharmacoimmunodynamics of methylprednisolone: trafficking of helper T lymphocytes.
    Fisher LE; Ludwig EA; Jusko WJ
    J Pharmacokinet Biopharm; 1992 Aug; 20(4):319-31. PubMed ID: 1479558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone.
    Chow FS; Sharma A; Jusko WJ
    J Pharmacokinet Biopharm; 1999 Dec; 27(6):559-75. PubMed ID: 11153446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm.
    Fisher LE; Ludwig EA; Wald JA; Sloan RR; Middleton E; Jusko WJ
    Clin Pharmacol Ther; 1992 Jun; 51(6):677-88. PubMed ID: 1535301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking.
    Milad MA; Ludwig EA; Anné S; Middleton E; Jusko WJ
    J Pharmacokinet Biopharm; 1994 Dec; 22(6):469-80. PubMed ID: 7473077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-compartment basophil cell trafficking model for methylprednisolone pharmacodynamics.
    Wald JA; Salazar DE; Chen HY; Jusko WJ
    J Pharmacokinet Biopharm; 1991 Oct; 19(5):521-36. PubMed ID: 1783990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity.
    Dunn TE; Ludwig EA; Slaughter RL; Camara DS; Jusko WJ
    Clin Pharmacol Ther; 1991 May; 49(5):536-49. PubMed ID: 1827621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.
    Lew KH; Ludwig EA; Milad MA; Donovan K; Middleton E; Ferry JJ; Jusko WJ
    Clin Pharmacol Ther; 1993 Oct; 54(4):402-14. PubMed ID: 8222483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylprednisolone pharmacokinetics and pharmacodynamics in chronic renal failure.
    Jusko WJ; Milad MA; Ludwig EA; Lew KH; Kohli RK
    Clin Nephrol; 1995 Jan; 43 Suppl 1():S16-9. PubMed ID: 7781199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and receptor-mediated pharmacodynamics of corticosteroids.
    Jusko WJ
    Toxicology; 1995 Sep; 102(1-2):189-96. PubMed ID: 7482553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects.
    Kong AN; Ludwig EA; Slaughter RL; DiStefano PM; DeMasi J; Middleton E; Jusko WJ
    Clin Pharmacol Ther; 1989 Dec; 46(6):616-28. PubMed ID: 2689044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers.
    Booker BM; Magee MH; Blum RA; Lates CD; Jusko WJ
    Clin Pharmacol Ther; 2002 Oct; 72(4):370-82. PubMed ID: 12386639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome.
    Cogan E; Schandené L; Crusiaux A; Cochaux P; Velu T; Goldman M
    N Engl J Med; 1994 Feb; 330(8):535-8. PubMed ID: 8302319
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics.
    Slayter KL; Ludwig EA; Lew KH; Middleton E; Ferry JJ; Jusko WJ
    Clin Pharmacol Ther; 1996 Mar; 59(3):312-21. PubMed ID: 8653994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodynamics of methylprednisolone induced T-cell trafficking and deactivation using whole blood lymphocyte proliferation techniques in the rat.
    Fasanmade AA; Jusko WJ
    Biopharm Drug Dispos; 1999 Jul; 20(5):255-61. PubMed ID: 10594870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic effects of coadministration of methylprednisolone and tacrolimus in rabbits.
    Piekoszewski W; Chow FS; Jusko WJ
    J Pharmacol Exp Ther; 1994 Apr; 269(1):103-9. PubMed ID: 7513355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid dose sparing: pharmacodynamic responses to single versus divided doses of methylprednisolone in man.
    Reiss WG; Slaughter RL; Ludwig EA; Middleton E; Jusko WJ
    J Allergy Clin Immunol; 1990 Jun; 85(6):1058-66. PubMed ID: 2191992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin A inhibits helper/inducer surface antigen expression on activated human lymphocytes.
    Marder P; Schmidtke JR
    Int J Immunopharmacol; 1985; 7(2):165-75. PubMed ID: 3159690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fifth-generation model for corticosteroid pharmacodynamics: application to steady-state receptor down-regulation and enzyme induction patterns during seven-day continuous infusion of methylprednisolone in rats.
    Ramakrishnan R; DuBois DC; Almon RR; Pyszczynski NA; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2002 Feb; 29(1):1-24. PubMed ID: 12194533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of low doses of prednisolone on the traffic of T helper-inducer cells in rheumatoid arthritis.
    Verbruggen G; Veys EM; Hermanns P; Delanghe J; Vansteenkiste M
    Clin Rheumatol; 1982 Sep; 1(3):199-207. PubMed ID: 6236014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortisol pharmacodynamics after methylprednisolone administration in young and elderly males.
    Tornatore KM; Logue G; Venuto RC; Davis PJ
    J Clin Pharmacol; 1997 Apr; 37(4):304-11. PubMed ID: 9115056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.